• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High prevalence of mixed infections in global onychomycosis.全球甲真菌病混合感染的高发率。
PLoS One. 2020 Sep 29;15(9):e0239648. doi: 10.1371/journal.pone.0239648. eCollection 2020.
2
Trichophyton rubrum DNA Strains in Patients with Onychomycosis with Persistent Mixed Infections Involving a Nondermatophyte Mold.红色毛癣菌 DNA 株在伴有非皮肤癣菌霉菌混合感染的持续性甲真菌病患者中的研究
J Am Podiatr Med Assoc. 2020 Nov 1;110(6). doi: 10.7547/17-201.
3
[Causative agents of onychomycosis--a retrospective study].[甲癣的致病原——一项回顾性研究]
J Dtsch Dermatol Ges. 2006 Mar;4(3):218-28. doi: 10.1111/j.1610-0387.2006.05877.x.
4
Mycology of nail disorders.指甲疾病的真菌学
J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S68-74. doi: 10.1016/s0190-9622(08)81272-8.
5
Clinico-mycological study of onychomycosis and in vitro antifungal susceptibility of Trichophyton rubrum.甲真菌病的临床-真菌学研究及红色毛癣菌的体外抗真菌药敏性。
Eur J Dermatol. 2024 Jun 1;34(3):260-266. doi: 10.1684/ejd.2024.4678.
6
Molecular determination of mixed infections of dermatophytes and nondermatophyte molds in individuals with onychomycosis.甲癣患者皮肤癣菌和非皮肤癣菌霉菌混合感染的分子检测
J Am Podiatr Med Assoc. 2014 Jul;104(4):330-6. doi: 10.7547/0003-0538-104.4.330.
7
Epidemiological and mycological data of onychomycosis in Goiania, Brazil.巴西戈亚尼亚甲真菌病的流行病学和真菌学数据。
Mycoses. 2010 Jan;53(1):68-71. doi: 10.1111/j.1439-0507.2008.01663.x. Epub 2009 Jan 21.
8
Office practice-based confirmation of onychomycosis: a US nationwide prospective survey.基于门诊实践的甲癣确诊:一项美国全国性前瞻性调查。
Arch Intern Med. 2002 Oct 14;162(18):2133-8. doi: 10.1001/archinte.162.18.2133.
9
Study of onychomycosis: prevailing fungi and pattern of infection.甲癣研究:优势真菌及感染模式
Indian J Med Microbiol. 2007 Jan;25(1):53-6. doi: 10.4103/0255-0857.31063.
10
Molecular Detection of Dermatophytes and Nondermatophytes in Onychomycosis in Antalya, Turkey.土耳其安塔利亚甲真菌病中皮肤癣菌和非皮肤癣菌的分子检测。
Clin Lab. 2024 Jun 1;70(6). doi: 10.7754/Clin.Lab.2024.231121.

引用本文的文献

1
[Scopulariopsis brevicaulis : The "arsenic fungus"-a difficult-to-treat pathogen].短帚霉:“砷真菌”——一种难以治疗的病原体
Dermatologie (Heidelb). 2025 Jun 25. doi: 10.1007/s00105-025-05526-9.
2
An Assessment of the Antifungal Efficacy of a Novel Topical Onychomycosis Treatment Using Human Nail and Skin Infection Models.使用人指甲和皮肤感染模型对一种新型外用甲真菌病治疗方法的抗真菌疗效评估。
J Fungi (Basel). 2025 Apr 29;11(5):345. doi: 10.3390/jof11050345.
3
The Dual Pathogen : Diseases, Incidence, Azole Resistance, and Biofilms.双重病原体:疾病、发病率、唑类耐药性和生物膜
J Fungi (Basel). 2025 Apr 9;11(4):294. doi: 10.3390/jof11040294.
4
Clinical and Onychoscopy Patterns In Fingernail Onychomycosis - A Study By The International Dermoscopy Society "Trichoscopy and Onychoscopy" Task Force.指甲甲癣的临床和甲下视镜模式——国际皮肤镜协会“毛发镜检和甲下视镜检查”特别工作组的一项研究
Dermatol Pract Concept. 2025 Jan 30;15(1):4887. doi: 10.5826/dpc.1501a4887.
5
Clinical and epidemiological study of onychomycosis among patients of the national institute of hygiene in rabat, Morocco (2016-2020).摩洛哥拉巴特国家卫生研究所患者甲癣的临床与流行病学研究(2016 - 2020年)
Curr Med Mycol. 2023 Dec;9(4):39-46. doi: 10.22034/CMM.2024.345174.1492.
6
Onychomycosis in Foot and Toe Malformations.足部和脚趾畸形中的甲癣
J Fungi (Basel). 2024 May 31;10(6):399. doi: 10.3390/jof10060399.
7
Species distribution and antifungal susceptibility profiles of yeasts isolated from onychomycosis: a cross-sectional study with insights into emerging species.从甲真菌病中分离的酵母菌的物种分布和抗真菌药敏谱:一项具有新兴物种见解的横断面研究。
Antonie Van Leeuwenhoek. 2023 Dec 28;117(1):6. doi: 10.1007/s10482-023-01914-0.
8
In Vitro and Ex Vivo Biofilm-Forming Ability of and Isolated from a Mixed Onychomycosis Case.从一例混合性甲真菌病病例中分离出的[具体内容未给出]的体外和离体生物膜形成能力
J Fungi (Basel). 2023 Jun 23;9(7):696. doi: 10.3390/jof9070696.
9
Single-Point Nail Sampling to Diagnose Onychomycosis Caused by Non-Dermatophyte Molds: Utility of Polymerase Chain Reaction (PCR) and Histopathology.单点指甲采样诊断非皮肤癣菌性霉菌引起的甲真菌病:聚合酶链反应(PCR)和组织病理学的应用
J Fungi (Basel). 2023 Jun 14;9(6):671. doi: 10.3390/jof9060671.
10
Comparative study of safety and efficacy of combination therapy of fractional CO laser and topical amorolfine cream versus oral itraconazole in the treatment of onychomycosis.比较研究分粹 CO2 激光联合外用阿莫罗芬乳膏与口服伊曲康唑治疗甲真菌病的安全性和疗效。
Lasers Med Sci. 2023 Jun 24;38(1):147. doi: 10.1007/s10103-023-03804-3.

本文引用的文献

1
Recent Findings in Onychomycosis and Their Application for Appropriate Treatment.甲癣的最新研究发现及其在适当治疗中的应用
J Fungi (Basel). 2019 Feb 22;5(1):20. doi: 10.3390/jof5010020.
2
Epidemiological survey of onychomycosis pathogens in Japan by real-time PCR.日本应用实时 PCR 进行甲真菌病病原菌的流行病学调查。
Med Mycol. 2019 Aug 1;57(6):675-680. doi: 10.1093/mmy/myy096.
3
A cohort study of risk factors, clinical presentations, and outcomes for dermatophyte, nondermatophyte, and mixed toenail infections.一项关于皮肤癣菌、非皮肤癣菌及混合性趾甲感染的危险因素、临床表现及转归的队列研究。
J Am Acad Dermatol. 2018 Dec;79(6):1145-1146. doi: 10.1016/j.jaad.2018.05.041. Epub 2018 May 31.
4
Onychomycosis Infections甲癣感染
J Am Podiatr Med Assoc. 2017 Jul;107(4):280-286. doi: 10.7547/15-136.
5
The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians' offices.在加拿大一个多中心的、有30000名患者前往医生办公室就诊的样本中,未被怀疑的甲真菌病及其致病生物体的患病率。
J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1567-72. doi: 10.1111/jdv.13677. Epub 2016 May 11.
6
Onychomycosis due to opportunistic molds.由机会性霉菌引起的甲癣
An Bras Dermatol. 2015 May-Jun;90(3):334-7. doi: 10.1590/abd1806-4841.20153521. Epub 2015 Jun 1.
7
The nondermatophyte molds: Emerging as leading cause of onychomycosis in south-east Rajasthan.非皮肤癣菌性霉菌:在拉贾斯坦邦东南部逐渐成为甲癣的主要病因。
Indian Dermatol Online J. 2015 Mar-Apr;6(2):92-7. doi: 10.4103/2229-5178.153010.
8
Molecular determination of mixed infections of dermatophytes and nondermatophyte molds in individuals with onychomycosis.甲癣患者皮肤癣菌和非皮肤癣菌霉菌混合感染的分子检测
J Am Podiatr Med Assoc. 2014 Jul;104(4):330-6. doi: 10.7547/0003-0538-104.4.330.
9
Trichophyton rubrum DNA strain switching increases in patients with onychomycosis failing antifungal treatments.红色毛癣菌 DNA 株系转换在抗真菌治疗失败的甲真菌病患者中增加。
Br J Dermatol. 2015 Jan;172(1):74-80. doi: 10.1111/bjd.13165. Epub 2014 Nov 30.
10
Fungal nail infections (onychomycosis): a never-ending story?甲真菌病:一个没完没了的故事?
PLoS Pathog. 2014 Jun 5;10(6):e1004105. doi: 10.1371/journal.ppat.1004105. eCollection 2014 Jun.

全球甲真菌病混合感染的高发率。

High prevalence of mixed infections in global onychomycosis.

机构信息

Department of Medicine, the University of Toronto, Toronto, Ontario, Canada.

Mycology Section, Mediprobe Research Inc., London, Ontario, Canada.

出版信息

PLoS One. 2020 Sep 29;15(9):e0239648. doi: 10.1371/journal.pone.0239648. eCollection 2020.

DOI:10.1371/journal.pone.0239648
PMID:32991597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7523972/
Abstract

Onychomycosis is estimated at a prevalence of 10% worldwide with the infecting organism most commonly Trichophyton rubrum (T. rubrum). Traditional culture identification of causative organisms has inherent risks of overestimating dermatophytes, like T. rubrum, by inhibiting the growth of possible nondermatophyte mould (NDM) environmental contaminants which could be causative agents. Recently, molecular methods have revealed that a proportion of onychomycosis cases in North America may be caused by mixed infections of T. rubrum as an agent co-infecting with one or more NDM. Determining the global burden of mixed infections is a necessary step to evaluating the best therapies for this difficult-to-treat disease. To determine the prevalence of mixed infections in a global population, nail samples from onychomycosis patients in Brazil, Canada, and Israel (n = 216) were analyzed by molecular methods for the presence of dermatophytes and five NDMs. If an NDM was detected, repeat sampling was performed to confirm the NDM. T. rubrum was detected in 98% (211/216) of infections with 39% mixed (84/216). The infection type was more likely to be mixed in samples from Brazil, but more likely to be a dermatophyte in samples from Canada and Israel (Χ2 = 16.92, df = 2, P<0.001). The most common cause of onychomycosis was T. rubrum. In all countries (Brazil, Canada and Israel combined) the prevalence of dermatophyte (Χ2 = 211.15, df = 3, P<0.001) and mixed (dermatophyte and NDM; Χ2 = 166.38, df = 3, P<0.001) infection increased with patient age. Our data suggest that mixed infection onychomycosis is more prevalent than previously reported with the aging population being at increased risk for mixed infections.

摘要

甲真菌病的全球患病率估计为 10%,最常见的致病微生物为红色毛癣菌(T. rubrum)。传统的致病微生物培养鉴定方法存在固有风险,可能会高估红色毛癣菌等皮肤癣菌,因为它会抑制可能为非皮肤癣菌的环境污染物(NDM)的生长,而这些污染物可能是致病因素。最近,分子方法显示,北美洲部分甲真菌病病例可能是由红色毛癣菌与一种或多种 NDM 混合感染引起的。确定混合感染的全球负担是评估这种难治性疾病最佳治疗方法的必要步骤。为了确定全球人群中混合感染的流行率,对来自巴西、加拿大和以色列的甲真菌病患者(n=216)的指甲样本进行了分子方法分析,以确定是否存在皮肤癣菌和五种 NDM。如果检测到 NDM,则进行重复采样以确认 NDM。98%(211/216)的感染中检测到红色毛癣菌,其中 39%(84/216)为混合感染。巴西样本中感染类型更可能为混合感染,但加拿大和以色列样本中更可能为皮肤癣菌感染(Χ2=16.92,df=2,P<0.001)。最常见的甲真菌病病因是红色毛癣菌。在所有国家(巴西、加拿大和以色列),皮肤癣菌(Χ2=211.15,df=3,P<0.001)和混合感染(皮肤癣菌和 NDM;Χ2=166.38,df=3,P<0.001)的患病率均随患者年龄的增长而增加。我们的数据表明,混合感染性甲真菌病的患病率高于以往报道,老年人群面临更高的混合感染风险。